SCHEMBL6172610

SCHEMBL6172610

COC(=O)C=Cc1ccc(C(C)=O)cc1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MAPT P10636 7/20 0.45
ALDH1A1 P00352 6/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
ATM Q13315 1/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172600 1.00 PTGS2 (0.48) PTGS2MEN1KMT2AMAPTALDH1A1
SCHEMBL9384428 0.85 VCAM1 (0.53) PTGS2MEN1KMT2AMAPTALDH1A1
SCHEMBL9384423 0.85 VCAM1 (0.53) PTGS2MEN1KMT2AMAPTALDH1A1
SCHEMBL8126644 0.85 MAPT (0.59) PTGS2MEN1KMT2AMAPTALDH1A1
SCHEMBL8126642 0.85 MAPT (0.59) PTGS2MEN1KMT2AMAPTALDH1A1
SCHEMBL8126650 0.85 MAPT (0.59) PTGS2MEN1KMT2AMAPTALDH1A1
SCHEMBL3071975 0.84 KMT2A (0.57) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL3601937 0.84 KMT2A (0.57) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL7204425 0.83 PTGS2 (0.50) PTGS2MEN1KMT2AMAPTALDH1A1
SCHEMBL13145899 0.83 ALDH1A1 (0.60) PTGS2MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed